UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b)

TELA Bio Inc
(Name of Issuer)

Common Stock
(Title of Class of Securities)

872381108
(CUSIP Number)

June 11, 2021
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[ ] Rule 13d-1(b)
[X ] Rule 13d-1(c)
[ ] Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 872381108

13G

Page 2 of 9 Pages

1.
NAMES OF REPORTING PERSONS OR
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Pura Vida Investments, LLC


2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)

(a) [    ]
(b) [ x ]
3.
SEC USE ONLY


4.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware



NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER

 0

6.
SHARED VOTING POWER
757,524*


7.
SOLE DISPOSITIVE POWER

0

8.
SHARED DISPOSITIVE POWER

757,524*

9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
757,524*


10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) [  ]


11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

  5.25%*

12.
TYPE OF REPORTING PERSON (see instructions)

 IA







CUSIP No. 872381108

13G

Page 3 of 9 Pages

1.
NAMES OF REPORTING PERSONS OR
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Efrem Kamen


2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)

(a) [    ]
(b) [ x ]
3.
SEC USE ONLY


4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 United States of America


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER

 0

6.
SHARED VOTING POWER
757,524*


7.
SOLE DISPOSITIVE POWER

 0

8.
SHARED DISPOSITIVE POWER
757,524*


9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
757,524*


10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) [  ]


11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.25%*


12.
TYPE OF REPORTING PERSON (see instructions)

 IN, HC










CUSIP No. 872381108

13G

Page 4 of 9 Pages

Item 1.

(a)
Name of Issuer


TELA Bio Inc




(b)
Address of Issuer's Principal Executive Offices

1 Great Valley Parkway, Suite 24, Malvern, PA 19355

Item 2.

(a)
Name of Person Filing

Pura Vida Investments, LLC
Efrem Kamen
(collectively, the "Filers").




(b)
The address of the principal place of the Filers is located at:

Pura Vida Investments, LLC
150 East 52nd Street Suite 32001
New York, New York 10022




(c)
 For citizenship of Filers, see Item 4 of the cover sheet for each Filer.



(d)
Title of Class of Securities

Common Stock




(e)
CUSIP Number

872381108

Item 3. If this statement is filed pursuant to
240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:


(a)
[  ]
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).





(b)
[  ]
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).





(c)
[  ]
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).





(d)
[  ]
Investment company registered under section 8
of the Investment Company Act of 1940 (15 U.S.C. 80a-8).



(e)
[X]
An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);





















CUSIP No. 872381108

13G

Page 5 of 9 Pages













(g)
[  ]
A parent holding company or control person in accordance
with 240.13d-1(b)(1)(ii)(G);





(h)
[  ]
A savings associations as defined in Section 3(b)
of the Federal Deposit Insurance Act (12 U.S.C. 1813);





(i)
[  ]
A church plan that is excluded from the definition of an investment company
under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);





(j)
[  ]
Group, in accordance with 240.13d-1(b)(1)(ii)(J).



CUSIP No. 872381108

13G

Page 6 of 9 Pages

Item 4. Ownership.

(a) Amount beneficially owned:

Pura Vida Investments, LLC  757,524* shares
Efrem Kamen  757,524* shares

(b) Percent of class:

Pura Vida Investments, LLC  5.25%*
Efrem Kamen  5.25%*

(c) Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote

       0

(ii) Shared power to vote or to direct the vote

Pura Vida Investments, LLC 757,524* shares
Efrem Kamen 757,524* shares

(iii) Sole power to dispose or to direct the disposition of

       0

(iv) Shared power to dispose or to direct the disposition of

Pura Vida Investments, LLC 757,524* shares
Efrem Kamen 757,524* shares

*Shares reported herein are held by Pura Vida Master Fund, Ltd.
(the 'Pura Vida Master Fund'), and certain separately managed accounts
(the 'Accounts'). Pura Vida Investments, LLC ('PVI')
serves as the investment manager to the Pura Vida Master Fund and the Accounts.
Efrem Kamen serves as the managing member of PVI.
By virtue of these relationships, the Reporting Persons may be deemed to have
shared voting and dispositive power with respect to the Shares owned directly
by the Pura Vida Master Fund and the Accounts. This report shall not be deemed
an admission that the Reporting Persons are beneficial owners of the Shares
for purposes of Section 13 of the Securities Exchange Act of 1934, as amended,
or for any other purpose. Each of the Reporting Persons disclaims beneficial
ownership of the Shares reported herein except to the extent of the
Reporting Person's pecuniary interest therein.
The percentages herein are calculated based upon a statement in the Issuer's
Form 10-Q filed on May 14, 2021 that there were 14,440,412 shares
of Common Stock issued and outstanding.

Item 5. Ownership of Five Percent or Less of a Class.

N/A



CUSIP No. 872381108

13G

Page 7 of 9 Pages

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

N/A

Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding Company.

N/A
Item 8. Identification and Classification of Members of the Group.

N/A

Item 9. Notice of Dissolution of Group.

N/A




CUSIP No. 872381108

13G

Page 8 of 9 Pages

Item 10. Certification.

By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.



SIGNATURE


After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.

Dated: June 21, 2021



Pura Vida Investments, LLC


________________________________________
By: /s/         Efrem Kamen, Managing Member




CUSIP No. 872381108

13G

Page 9 of 9 Pages

EXHIBIT A
AGREEMENT REGARDING JOINT FILING
OF STATEMENT ON SCHEDULE 13D OR 13G
Statement Pursuant to Rule 13d-1(k)(1)
The undersigned hereby consent and agree to file a joint statement
on Schedule 13G under the Securities Exchange Act of 1934, as amended,
with respect to the Common Stock of TELA Bio Inc. beneficially owned by them,
together with any or all amendments thereto, when and if appropriate.
The parties hereto further consent this Statement pursuant to
Rule 13d-1(k)(1)(iii) as an exhibit to Schedule 13G,
thereby incorporating the same into such Schedule 13G.





Dated: June 21, 2021



Pura Vida Investments, LLC



By: /s/         Efrem Kamen, Managing Member


*Shares reported herein are held by Pura Vida Master Fund, Ltd.
(the 'Pura Vida Master Fund'), and
certain separately managed accounts (the 'Accounts').
Pura Vida Investments, LLC ('PVI') serves as the investment manager
to the Pura Vida Master Fund and the Accounts.
Efrem Kamen serves as the managing member of PVI.

By virtue of these relationships, the Reporting Persons may be deemed to have
shared voting and dispositive power with respect to the Shares owned directly
by the Pura Vida Master Fund and the Accounts. This report shall not be deemed
an admission that the Reporting Persons are beneficial owners of the Shares for
purposes of Section 13 of the Securities Exchange Act of 1934, as amended,
or for any other purpose. Each of the Reporting Persons
disclaims beneficial ownership of the Shares reported herein except to the
extent of the Reporting Person's pecuniary interest therein.

The percentages herein are calculated based upon a statement in the
Issuer's Form 10-Q filed on May 14, 2021 that there were 14,440,412
shares of Common Stock issued and outstanding.



This regulatory filing also includes additional resources:
TelaBioInc_13G.pdf
TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From Sep 2021 to Oct 2021 Click Here for more TELA Bio Charts.
TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From Oct 2020 to Oct 2021 Click Here for more TELA Bio Charts.